BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Albert S, Hourseau M, Halimi C, Serova M, Descatoire V, Barry B, Couvelard A, Riveiro ME, Tijeras-Raballand A, de Gramont A. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Oral Oncol. 2012;48:1263-1271. [PMID: 22776129 DOI: 10.1016/j.oraloncology.2012.06.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Hou KZ, Fu ZQ, Gong H. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. World J Gastroenterol 2015; 21(2): 475-483 [PMID: 25593462 DOI: 10.3748/wjg.v21.i2.475] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
2 De-Colle C, Mönnich D, Welz S, Boeke S, Sipos B, Fend F, Mauz PS, Tinhofer I, Budach V, Jawad JA, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Lohaus F, Linge A, Krause M, Baumann M, Zips D, Menegakis A. SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy. Clin Transl Radiat Oncol 2017;5:28-36. [PMID: 29594214 DOI: 10.1016/j.ctro.2017.06.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
3 Li K, Zhang C, Chen L, Wang P, Fang Y, Zhu J, Chen S, Du J, Shen B, Wu K, Liu Y. The role of acetyl-coA carboxylase2 in head and neck squamous cell carcinoma. PeerJ 2019;7:e7037. [PMID: 31218122 DOI: 10.7717/peerj.7037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Barnett CM, Sommerville RS, Lin C, Ratnayake G, Hughes B, Taheri T. CXCR4 and PD-1 Expression in Head and Neck Cancer with Perineural Spread. J Neurol Surg B Skull Base 2019;80:18-22. [PMID: 30733896 DOI: 10.1055/s-0038-1660846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Hussein AA, Forouzanfar T, Bloemena E, de Visscher J, Brakenhoff RH, Leemans CR, Helder MN. A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma. Br J Cancer 2018;119:724-36. [PMID: 30131545 DOI: 10.1038/s41416-018-0233-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
6 Schmitz S, Machiels JP. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck. Curr Treat Options Oncol 2016;17:37. [PMID: 27262711 DOI: 10.1007/s11864-016-0412-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
7 León X, Diez S, García J, Lop J, Sumarroca A, Quer M, Camacho M. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2016;273:4525-33. [PMID: 27328961 DOI: 10.1007/s00405-016-4144-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
8 Elhousiny M, Miller K, Ariyawadana A, Nimmo A. Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review. Clin Exp Metastasis 2019;36:481-92. [PMID: 31559586 DOI: 10.1007/s10585-019-09994-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Almangush A, Heikkinen I, Mäkitie AA, Coletta RD, Läärä E, Leivo I, Salo T. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer 2017;117:856-66. [PMID: 28751758 DOI: 10.1038/bjc.2017.244] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 19.3] [Reference Citation Analysis]
10 Parzefall T, Schnoell J, Monschein L, Foki E, Liu DT, Frohne A, Grasl S, Pammer J, Lucas T, Kadletz L, Brunner M. PRKCA Overexpression Is Frequent in Young Oral Tongue Squamous Cell Carcinoma Patients and Is Associated with Poor Prognosis. Cancers (Basel) 2021;13:2082. [PMID: 33923093 DOI: 10.3390/cancers13092082] [Reference Citation Analysis]
11 Noguchi S, Hattori A, Tanimoto N, Nishida R, Hirano K, Wada Y, Matsuyama S, Shimada T, Akiyoshi H. Establishing cell lines for canine tonsillar and non-tonsillar oral squamous cell carcinoma and identifying characteristics associated with malignancy. Tissue Cell 2020;67:101408. [PMID: 32835941 DOI: 10.1016/j.tice.2020.101408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Clatot F, Cornic M, Berghian A, Marchand V, Choussy O, El Ouakif F, François A, Ruminy P, Laberge-Le-Couteulx S, Picquenot JM, Jardin F. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma. Pathology 2015;47:45-50. [PMID: 25474514 DOI: 10.1097/PAT.0000000000000191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Zainal NS, Gan CP, Lau BF, Yee PS, Tiong KH, Abdul Rahman ZA, Patel V, Cheong SC. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells. Phytomedicine 2018;39:33-41. [DOI: 10.1016/j.phymed.2017.12.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
14 Yang P, Hu Y, Zhou Q. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer. Curr Med Chem 2020;27:5543-61. [PMID: 31724498 DOI: 10.2174/0929867326666191113113110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 da Silva JM, Soave DF, Moreira dos Santos TP, Batista AC, Russo RC, Teixeira MM, Silva TAD. Significance of chemokine and chemokine receptors in head and neck squamous cell carcinoma: A critical review. Oral Oncology 2016;56:8-16. [DOI: 10.1016/j.oraloncology.2016.02.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
16 Zhao H, Guo L, Zhao H, Zhao J, Weng H, Zhao B. CXCR4 over-expression and survival in cancer: a system review and meta-analysis. Oncotarget 2015;6:5022-40. [PMID: 25669980 DOI: 10.18632/oncotarget.3217] [Cited by in Crossref: 112] [Cited by in F6Publishing: 123] [Article Influence: 22.4] [Reference Citation Analysis]
17 Zhang K, Zhou H, Yan B, Cao X. TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma. Cancer Cell Int 2020;20:148. [PMID: 32390763 DOI: 10.1186/s12935-020-01224-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
18 De-Colle C, Menegakis A, Mönnich D, Welz S, Boeke S, Sipos B, Fend F, Mauz PS, Tinhofer I, Budach V, Abu Jawad J, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Belka C, Ganswindt U, Pigorsch S, Combs SE, Lohaus F, Linge A, Krause M, Baumann M, Zips D; DKTK-ROG. SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy. Radiother Oncol 2018;126:125-31. [PMID: 29061496 DOI: 10.1016/j.radonc.2017.10.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
19 Zhou B, Zhuang X, Wang Y, Lin Z, Zhang D, Fan S, Li J, Chen W. Tumor necrosis factor α induces myofibroblast differentiation in human tongue cancer and promotes invasiveness and angiogenesis via secretion of stromal cell-derived factor-1. Oral Oncology 2015;51:1095-102. [DOI: 10.1016/j.oraloncology.2015.08.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
20 Al-Jokhadar M, Al-Mandily A, Zaid Kh, Azar Maalouf E. CCR7 and CXCR4 Expression in Primary Head and Neck Squamous Cell Carcinomas and Nodal Metastases – a Clinical and Immunohistochemical Study. Asian Pac J Cancer Prev 2017;18:1093-104. [PMID: 28547946 DOI: 10.22034/APJCP.2017.18.4.1093] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Bredell MG, Ernst J, El-Kochairi I, Dahlem Y, Ikenberg K, Schumann DM. Current relevance of hypoxia in head and neck cancer. Oncotarget 2016;7:50781-804. [PMID: 27434126 DOI: 10.18632/oncotarget.9549] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
22 Karpathiou G, Casteillo F, Giroult JB, Forest F, Fournel P, Monaya A, Froudarakis M, Dumollard JM, Prades JM, Peoc'h M. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics. Oncotarget 2017;8:19310-22. [PMID: 28038471 DOI: 10.18632/oncotarget.14242] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 13.8] [Reference Citation Analysis]
23 Ding L, Zhang Z, Shang D, Cheng J, Yuan H, Wu Y, Song X, Jiang H. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma. J Oral Pathol Med 2014;43:335-43. [PMID: 24313357 DOI: 10.1111/jop.12143] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]